Abstract

Leidos will report fiscal results on August 04, 2026 Pre-Market; this preview compiles consensus forecasts for revenue, margins, net income, and adjusted EPS alongside segment drivers and institutional views since January 01, 2026.

Market Forecast

The market expects Leidos’s current quarter revenue at 4.43 billion US dollars, with forecast year-over-year growth of 4.68%, EBIT of 0.54 billion US dollars with 8.63% growth, and EPS of 2.89 with 8.81% growth. The company’s prior report implies a last quarter actual revenue baseline of 4.40 billion US dollars, and consensus anticipates stable-to-slightly higher gross margin and net profit margin around the recent levels, with adjusted EPS trending up year-over-year. The main businesses are expected to see modest momentum: Intelligent & Digital, Health, Defense Systems, and Homeland-focused work continue to drive revenue, with Intelligent & Digital remaining the largest at 1.51 billion US dollars last quarter. The most promising segment is Intelligent & Digital, supported by enterprise modernization and cyber demand; last quarter revenue reached 1.51 billion US dollars.

Last Quarter Review

Leidos reported last quarter revenue of 4.40 billion US dollars, a gross profit margin of 17.30%, net profit attributable to the parent company of 0.33 billion US dollars, a net profit margin of 7.45%, and adjusted EPS of 3.13, with revenue up 3.65% year-over-year and adjusted EPS up 5.39% year-over-year. A key highlight was outperformance versus consensus across revenue and earnings, with EBIT of 0.57 billion US dollars and adjusted EPS of 3.13 surpassing estimates. Segment performance was led by Intelligent & Digital at 1.51 billion US dollars, Health at 1.19 billion US dollars, Defense Systems at 0.88 billion US dollars, and Homeland-related work at 0.82 billion US dollars.

Current Quarter Outlook (with major analytical insights)

Main business trajectory and revenue quality

Leidos’s diversified book features federal modernization, cyber, and mission IT programs that tend to exhibit stable funding and multi-year visibility. Given the revenue estimate of 4.43 billion US dollars and positive year-over-year growth, backlog conversion should remain the primary driver, while the net margin framework near 7% indicates disciplined pricing and cost control. Watch for mix dynamics between cost-plus and fixed-price contracts, which can influence gross margin drift relative to the recent 17.30% level.

Program execution and labor availability remain central to revenue quality. Elevated clearance demand and wage inflation in technical roles can pressure contract profitability, but the EBIT estimate of 0.54 billion US dollars and EPS of 2.89 suggest absorption is manageable. Contract wins announced in the period and option-year rollovers are likely to provide incremental tailwinds, though timing can skew intra-quarter phasing.

Cash conversion and working capital discipline are relevant for EPS sustainability. If milestone billing and collections remain in line with the prior quarter’s cadence, free cash flow support for capital allocation could remain intact. Any deviation in billing cycles tied to federal fiscal-year dynamics may introduce short-term noise in margins and EPS cadence.

Most promising growth vector and catalysts

Intelligent & Digital appears best positioned to outgrow the portfolio, supported by sustained demand for enterprise IT modernization, cloud migration, and cybersecurity. With a last-quarter revenue base of 1.51 billion US dollars, even mid-single-digit growth can add meaningful absolute dollars this quarter. Emerging opportunities in AI-enabled analytics and zero-trust architectures can favor higher-value solutions, potentially lifting EBIT mix over time.

Health-related programs should provide steady volume, benefiting from ongoing civilian agency needs and digital transformation. While the segment’s cost structure is typically predictable, contract transitions and ramp-ups can affect near-term margins. Consistent task-order awards and expansions in health IT services can underpin sequential stability in revenue and profitability.

Defense Systems remains levered to mission systems and C5ISR demand. As modernization cycles continue, hardware-heavy programs can create lumpiness, while services-heavy work stabilizes utilization. Any large new-starts or production ramps would skew upside, but timing risks are notable given testing and delivery milestones. Net of these factors, the portfolio’s diversity aligns with the consensus call for mid-single-digit revenue expansion.

Key stock-price swing factors this quarter

The margin trajectory relative to the recent 17.30% gross margin and roughly mid- to high-7% net margin will be closely watched. Upside could come from richer solution mix in Intelligent & Digital, while downside risks include wage pressure, subcontractor inflation, and schedule changes. Commentary on pricing discipline and any unexpected cost growth will shape post-print reactions.

Book-to-bill and backlog updates will be critical sentiment drivers. A bookings beat implying a book-to-bill above 1.0 would validate out-year revenue visibility and support EPS durability; a shortfall could prompt questions on growth into 2027. Any disclosures on large recompetes or protest outcomes may add volatility.

Guidance color on EPS and revenue cadence through the government fiscal year can move shares. An outlook consistent with estimated EPS of 2.89 and revenue growth of 4.68% would likely support a constructive reaction. Conversely, a guide implying slower second-half execution or heavier investment spend could pressure near-term multiples.

Analyst Opinions

The majority of institutional commentary in the period skews bullish, citing resilient federal funding, stable backlog conversion, and improving mix within higher-margin digital solutions. Analysts highlighting the upcoming print expect revenue near 4.43 billion US dollars and EPS near 2.89, implying healthy year-over-year growth and reinforcing a constructive margin framework. Upbeat views also point to continued traction in cyber and cloud services that could sustain book-to-bill near or above 1.0.

Commentary from well-followed research desks argues that Leidos’s positioning across federal civilian and defense IT should support a steady mid-single-digit growth profile with incremental margin lift as solution mix improves. The bullish camp emphasizes execution on recent awards and the durability of demand across enterprise modernization and cybersecurity. These analysts argue that risks from wage inflation and contract transitions are manageable within the current EBIT outlook of about 0.54 billion US dollars, supporting the projected EPS of 2.89 for the quarter.

Overall, bullish opinions appear to outnumber bearish takes this quarter. The constructive consensus expects Leidos to deliver in line with or slightly above estimates, with Intelligent & Digital as the leading growth vector and stable performance in Health and Defense Systems shoring up results.